trending Market Intelligence /marketintelligence/en/news-insights/trending/ab3rbjzymo0zgk_9i39bsg2 content
Log in to other products

Login to Market Intelligence Platform


Looking for more?

Contact Us

Request a Demo

You're one step closer to unlocking our suite of comprehensive and robust tools.

Fill out the form so we can connect you to the right person.

If your company has a current subscription with S&P Global Market Intelligence, you can register as a new user for access to the platform(s) covered by your license at Market Intelligence platform or S&P Capital IQ.

  • First Name*
  • Last Name*
  • Business Email *
  • Phone *
  • Company Name *
  • City *
  • We generated a verification code for you

  • Enter verification Code here*

* Required

Thank you for your interest in S&P Global Market Intelligence! We noticed you've identified yourself as a student. Through existing partnerships with academic institutions around the globe, it's likely you already have access to our resources. Please contact your professors, library, or administrative staff to receive your student login.

At this time we are unable to offer free trials or product demonstrations directly to students. If you discover that our solutions are not available to you, we encourage you to advocate at your university for a best-in-class learning experience that will help you long after you've completed your degree. We apologize for any inconvenience this may cause.

In This List

Moody's downgrades Rite Aid, changes outlook to negative

Gauging Supply Chain Risk In Volatile Times

S&P Global Market Intelligence

Cannabis: Hashing Out a Budding Industry


IFRS 9 Impairment How It Impacts Your Corporation And How We Can Help

The Market Intelligence Platform

Moody's downgrades Rite Aid, changes outlook to negative

Moody's on Oct. 15 downgraded Rite Aid Corp.'s corporate family rating to B3 from B2 and its probability of default rating to B3-PD from B2-PD.

The agency also changed the outlook to negative from under review.

The downgrade concludes the review that Moody's started in August, following Rite Aid's aborted merger deal with Albertsons Cos. Inc.

The agency said that the nixed merger placed the Rite Aid in a weaker position as it does not have the scale or balance sheet to effectively compete in the U.S. pharmacy industry against bigger competitors like CVS Health Corp. and Walgreens Boots Alliance Inc.

"Despite the debt reduction through the proceeds of the asset sales to Walgreens, the company's leverage remains high due to EBITDA erosion and free cash flow remains weak," Moody's Vice President Mickey Chadha said in a statement. "Rite Aid's operating performance has been weak in the last 18 to 24 months and it has a much weaker competitive position vis-à-vis its much larger andwell-capitalizedd competitors in an industry where scale is becoming increasingly important, hence the downgrade."

Moody's said the negative outlook reflects its uncertainty in the company's ability to turn around its operating performance and credit metrics in the next 12 to 18 months.

Moody's also said it can upgrade Rite Aid's ratings if it improves its operating performance, or reduce its absolute debt levels such that it can maintain debt/EBITDA below 5.5 times and EBIT to interest expense above 1.5 times.